STOCKHOLM — Sweden’s Health Agency said on Wednesday it would pause plans to start vaccinations using Johnson & Johnson’s COVID-19 vaccine following reports of rare blood clots similar to those reported for the AstraZeneca shot.
The Health Agency said in a statement it would not start the vaccinations and await the findings of a review by the European Medicines Agency (EMA). The vaccine has not yet been used in Sweden though a first batch of 31,000 doses has arrived in the country.
U.S. federal health agencies have recommended pausing the use of the Johnson & Johnson (J&J) COVID-19 vaccine after six recipients developed a rare disorder involving blood clots. Follo…
Keep on reading: Sweden pauses plans for J&J COVID-19 vaccinations, awaits review